Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

SIMPLE SUMMARY: Dysregulated B-cell receptor (BCR) signaling is considered a potent contributor to tumor survival in different subtypes of B-cell non-Hodgkin lymphomas (B-NHLs). In the last decade, BCR-targeted therapies have emerged as promising alternative treatment options to standard chemoimmuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Profitós-Pelejà, Núria, Santos, Juliana Carvalho, Marín-Niebla, Ana, Roué, Gaël, Ribeiro, Marcelo Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870007/
https://www.ncbi.nlm.nih.gov/pubmed/35205606
http://dx.doi.org/10.3390/cancers14040860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870007/
https://www.ncbi.nlm.nih.gov/pubmed/35205606
http://dx.doi.org/10.3390/cancers14040860

Ejemplares similares